FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

7 letters match. Newest first.

  1. MolluscumRx, Inc.

    FDA told MolluscumRx, Inc. of Orlando, Florida that its molluscum lotion and soap are unapproved new drugs sold with unsupported cure claims.

    High risk
  2. Walmart, Inc

    FDA warned Walmart over selling Naturasil Molluscum Treatment Kit, an unapproved new drug for molluscum.

    High risk
  3. King Systems Corp. dba Ambu, Inc.

    FDA warns Ambu's King Systems over unapproved King LTS-D airway device and pediatric website claims.

    High risk
  4. ALVA-AMCO Pharmacal Companies, LLC

    FDA warns ALVA-AMCO that Nauzene Kids, a children’s nausea drug, is an unapproved new drug.

    High risk
  5. NeilMed Pharmaceuticals Inc.

    FDA warned NeilMed Pharmaceuticals that its OTC drug manufacturing had current good manufacturing practice violations, including missing glycerin identity testing and dirty equipment.

    High risk
  6. Champaklal Maganlal Homeo Pharmacy Private Limited

    FDA says Champaklal Maganlal Homeo Pharmacy's Bebelyn diarrhea and colic products are unapproved new drugs for infants.

    High risk
  7. Dr. Green Mom, LLC

    FDA warned Dr. Green Mom, LLC that its vitamin, zinc, immunity and colloidal silver products are unapproved new drugs because of disease claims on its website.

    High risk